Eisai Ltd ADR (ESALY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ESALY | NBIX | MDGL | ||
| Company | Eisai Ltd ADR | Neurocrine Bioscienc | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 62.5000 | 177.11 | 534.50 | ||
| High | 63.2900 | 177.11 | 534.50 | ||
| Low | 61.0000 | 177.11 | 534.50 | ||
| Latest | 61.5100 | 177.11 | 534.50 | ||
| Change | -1.3250 | unch | -2.20 | ||
| % Change | -2.11% | unch | -0.41% | ||
| Volume | 331,801 | 272 | 931 | ||
| 20-Day Average Volume | 58,360 | 1,155,839 | 421,982 | ||
| Previous Close | 62.8350 | 177.11 | 536.70 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 64.1255 | 168.00 | 521.40 | ||
| 20-Day Raw Stochastic | 13.14% | 84.27% | 65.19% | ||
| 20-Day Relative Strength | 42.88 | 65.45 | 54.60 | ||
| Weighted Alpha | +14.94 | +41.78 | +49.38 | ||
| Today's Opinion | 40% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 40% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 64% Buy | 88% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.08% since 01/23/23 | +1.73% since 07/06/26 | +0.95% since 07/06/26 | ||
| Low | 61.0000 on 01/30/23 | 174.21 on 07/10/26 | 529.50 on 07/10/26 | ||
| High | 64.7200 on 01/26/23 | 181.18 on 07/10/26 | 569.44 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | -7.24% since 12/30/22 | +10.86% since 06/12/26 | +11.18% since 06/12/26 | ||
| Low | 60.4000 on 01/05/23 | 155.30 on 06/16/26 | 474.52 on 06/15/26 | ||
| High | 68.8500 on 01/06/23 | 181.18 on 07/10/26 | 569.44 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +1.67% since 10/28/22 | +40.21% since 04/13/26 | +1.68% since 04/13/26 | ||
| Low | 56.8800 on 11/09/22 | 126.32 on 04/14/26 | 445.20 on 06/03/26 | ||
| High | 73.9035 on 12/05/22 | 181.18 on 07/10/26 | 569.44 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +34.10% since 07/29/22 | +33.91% since 01/13/26 | +8.22% since 01/13/26 | ||
| Low | 39.1540 on 09/07/22 | 122.14 on 02/12/26 | 416.21 on 03/03/26 | ||
| High | 73.9035 on 12/05/22 | 181.18 on 07/10/26 | 572.20 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,638,976 | 17,808,412 | 12,374,150 | ||
| Shares Outstanding, K | 286,766 | 100,550 | 23,056 | ||
| Annual Sales | 6,730,410,000 | 2,860,500,000 | 958,400,000 | ||
| Annual Net Income | 426,790,000 | 478,600,000 | -288,280,000 | ||
| Last Quarter Sales | 1,262,920,000 | 814,500,000 | 311,340,000 | ||
| Last Quarter Net Income | 25,840,000 | 197,900,000 | -94,390,000 | ||
| 60-Month Beta | 0.31 | 0.39 | -1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.09 on 11/07/22 | 1.94 on 05/05/26 | -3.25 on 05/06/26 | ||
| Earnings Date | 02/02/23 | 07/29/26 | 08/04/26 | ||
| Most Recent Dividend | 0.440 on 09/27/22 | N/A | N/A | ||
| Next Ex-Dividends Date | 09/27/22 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 72.22 | 30.40 | 0.00 | ||